Prevalence and risk factors for bone loss in rheumatoid arthritis patients from South China: modeled by three methods
Open Access
- 12 June 2021
- journal article
- research article
- Published by Springer Nature in BMC Musculoskeletal Disorders
- Vol. 22 (1) , 1-9
Abstract
Background: To explore the prevalence of bone loss among patients with rheumatoid arthritis (RA) and healthy controls (HC) and further explored the risk factors for osteopenia and osteoporosis of RA patients. Methods: A cross-sectional survey was undertaken in four hospitals in different districts in South China to reveal the prevalence of bone loss in patients. Case records, laboratory tests, and bone mineral density (BMD) results of patients were collected. Traditional multivariable logistic regression analysis and two machine learning methods, including least absolute shrinkage selection operator (LASSO) and random forest (RF) were for exploring the risk factors for osteopenia or osteoporosis in RA patients. Results: Four hundred five patients with RA and 198 HC were included. RA patients had lower BMD in almost BMD measurement sites than healthy controls; the decline of lumbar spine BMD was earlier than HC. RA patients were more likely to comorbid with osteopenia and osteoporosis (p for trend < 0.001) in the lumbar spine than HC. Higher serum 25-hydroxyvitamin D3 level and using tumor necrosis factor inhibitor in the last year were protective factors; aging, lower body mass index, and increased serum uric acid might be risk factors for bone loss. Conclusions: RA patients were more prone and earlier to have bone loss than HC. More attention should be paid to measuring BMD in RA patients aging with lower BMI or hyperuricemia. Besides, serum vitamin D and all three measurement sites are recommended to check routinely. TNFi usage in the last year might benefit bone mass.Keywords
This publication has 42 references indexed in Scilit:
- Vitamin D Status Is Associated with Disease Activity among Rheumatology OutpatientsNutrients, 2013
- Serum uric acid plays a protective role for bone loss in peri- and postmenopausal women: A longitudinal studyBone, 2013
- Stable bone mineral density in lumbar spine and hip in contrast to bone loss in the hands during long-term treatment with infliximab in patients with rheumatoid arthritisAnnals of the Rheumatic Diseases, 2011
- Bone mineral density in patients with recently diagnosed, active rheumatoid arthritisAnnals of the Rheumatic Diseases, 2007
- Vitamin D DeficiencyNew England Journal of Medicine, 2007
- A 1-year case-control study in patients with rheumatoid arthritis indicates prevention of loss of bone mineral density in both responders and nonresponders to infliximabArthritis Research & Therapy, 2007
- Increase in bone mineral density of patients with rheumatoid arthritis treated with anti-TNF-α antibody: a prospective open-label pilot studyRheumatology, 2005
- Prognostic modelling with logistic regression analysis: a comparison of selection and estimation methods in small data setsStatistics in Medicine, 2000
- Bone mineral density in systemic lupus erythematosus: comparison with rheumatoid arthritis and healthy controlsAnnals of the Rheumatic Diseases, 2000
- Rheumatoid ArthritisNew England Journal of Medicine, 1990